UMB Bank’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13
Closed -$240 2127
2024
Q4
$240 Sell
13
-62
-83% -$1.21K ﹤0.01% 2048
2024
Q3
$1.63K Buy
75
+14
+23% +$313 ﹤0.01% 2021
2024
Q2
$1.2K Buy
61
+49
+408% +$1.02K ﹤0.01% 1934
2024
Q1
$260 Buy
+12
New +$298 ﹤0.01% 2113

Other funds holding FLGT

UMB Bank's FLGT Position: Q1 2025 in Review

UMB Bank sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 13 shares — an estimated $240 sold.

UMB Bank first reported a position in FLGT in Q1 2024 and held it in 4 quarters. The position peaked at $1.63K in Q3 2024. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • UMB Bank reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • UMB Bank sold 13 Fulgent Genetics shares in Q1 2025, an estimated $240.
  • UMB Bank first reported a position in Fulgent Genetics in Q1 2024 and held it in 4 quarters.
  • UMB Bank's Fulgent Genetics position peaked at $1.63K in Q3 2024.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on UMB Bank's 13F filing for Q1 2025, filed 14 Apr 2025.